Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells

We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA). BMDCs treated with RG-II had an activated phenotype...

Full description

Bibliographic Details
Main Authors: Park, Sung Nam, Tae Noh, Kyung, Jeong, Young-Il, Duk Jung, In, Kyu Kang, Hyun, Sun Cha, Gil, Jung Lee, Su, Keun Seo, Jong, Hwan Kang, Dae, Hwang, Tae-Ho, Kyung Lee, Eun, Kwon, Byungsuk, Park, Yeong-Min
Format: Online
Language:English
Published: Nature Publishing Group 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584663/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584663/

Similar Items